Profile data is unavailable for this security.
About the company
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. Its lead asset, ATH434, is in a randomized, double blind, placebo-controlled Phase II clinical trial in participants with MSA. The Company is also conducting various nonclinical studies with ATH434 for use in Parkinson’s disease based on imaging of brain iron, preservation of neurons, and improvements in motor performance.
- Revenue in AUD (TTM)446.29k
- Net income in AUD-12.15m
- Incorporated1997
- Employees9.00
- LocationAlterity Therapeutics LtdLevel 14, 350 Collins StreetMELBOURNE 3000AustraliaAUS
- Phone+61 39349-4906
- Fax+61 39822-7735
- Websitehttps://alteritytherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entropy Neurodynamics Ltd | 1.59m | -5.33m | 50.05m | -- | -- | 7.72 | -- | 31.53 | -0.0043 | -0.0043 | 0.0012 | 0.0041 | 0.2249 | -- | 0.763 | -- | -75.55 | -- | -92.06 | -- | -- | -- | -335.91 | -- | -- | -100.79 | 0.00 | -- | -- | -10.25 | -- | -- | -26.73 | -- |
| Syntara Ltd | 7.48m | -12.26m | 52.26m | 107.00 | -- | 3.25 | -- | 6.99 | -0.0084 | -0.0054 | 0.0051 | 0.0099 | 0.4701 | -- | 2.53 | -- | -77.03 | -36.39 | -116.54 | -50.26 | -- | -- | -163.86 | -78.37 | -- | -953.38 | 0.0052 | -- | 37.80 | -9.83 | 10.31 | -- | -- | -- |
| Clever Culture Systems Ltd | 6.52m | 1.68m | 63.14m | 17.00 | 37.18 | 9.08 | 33.07 | 9.68 | 0.0008 | 0.0008 | 0.0031 | 0.0032 | 0.6975 | 0.9829 | 6.37 | -- | 18.01 | -36.73 | 22.73 | -42.00 | 77.05 | -- | 25.82 | -281.21 | 1.63 | -- | 0.2653 | -- | 397.86 | 30.08 | 145.03 | -- | 24.71 | -- |
| Amplia Therapeutics Ltd | 5.01m | -7.93m | 64.13m | 1.00 | -- | 1.49 | -- | 12.81 | -0.0204 | -0.0204 | 0.0128 | 0.0837 | 0.1705 | -- | 1.28 | -- | -27.01 | -27.37 | -28.31 | -30.38 | -- | -- | -158.46 | -180.53 | -- | -- | 0.0088 | -- | -15.01 | 156.11 | -45.93 | -- | -- | -- |
| Proteomics International LaboratoriesLtd | 3.31m | -8.11m | 65.25m | -- | -- | 4.90 | -- | 19.70 | -0.0605 | -0.0605 | 0.0247 | 0.0805 | 0.2582 | -- | 12.02 | -- | -63.57 | -63.62 | -68.88 | -71.91 | -- | -- | -246.18 | -222.10 | -- | -- | 0.021 | -- | 1.34 | 15.81 | -27.27 | -- | -54.88 | -- |
| Prescient Therapeutics Ltd | 225.61k | -7.32m | 68.35m | 3.00 | -- | 4.60 | -- | 302.95 | -0.0091 | -0.0091 | 0.0003 | 0.0141 | 0.0129 | -- | 0.9582 | -- | -41.90 | -31.70 | -49.69 | -34.33 | -- | -- | -3,245.66 | -2,146.75 | -- | -590.48 | 0.00 | -- | -67.19 | 26.24 | 11.11 | -- | -- | -- |
| Rhythm Biosciences Ltd | 3.33m | -3.83m | 68.68m | -- | -- | 92.39 | -- | 20.65 | -0.0134 | -0.0134 | 0.0124 | 0.0023 | 1.53 | 98.79 | 67.11 | -- | -176.04 | -146.24 | -469.96 | -197.40 | -10.44 | 22.48 | -115.14 | -287.42 | 0.8046 | -53.89 | 0.6266 | -- | 90.87 | 135.14 | 44.15 | -- | -12.61 | -- |
| Imugene Ltd | 0.00 | -69.02m | 81.99m | 0.00 | -- | 1.24 | -- | -- | -0.3161 | -0.3161 | 0.00 | 0.205 | 0.00 | -- | -- | -- | -58.75 | -48.72 | -75.21 | -53.73 | -- | -- | -- | -- | -- | -- | 0.1913 | -- | -- | -- | 53.89 | -- | 38.40 | -- |
| Alterity Therapeutics Ltd | 446.29k | -12.15m | 87.00m | 9.00 | -- | 1.72 | -- | 194.95 | -0.002 | -0.002 | 0.00007 | 0.0047 | 0.0137 | -- | 5,578.63 | 49,587.78 | -37.23 | -49.00 | -43.12 | -57.35 | -- | -- | -2,721.96 | -9,708.51 | -- | -211.82 | 0.0037 | -- | 66.27 | 91.97 | 36.48 | -- | -- | -- |
| Cynata Therapeutics Ltd | 227.70k | -9.39m | 87.86m | 0.00 | -- | 13.98 | -- | 385.85 | -0.0453 | -0.0453 | 0.0011 | 0.0265 | 0.0292 | -- | 2.16 | -- | -120.50 | -48.36 | -142.29 | -53.09 | -- | -- | -4,124.10 | -576.20 | -- | -1,268.00 | 0.00 | -- | -45.49 | 28.12 | 3.63 | -- | -- | -- |
| LTR Pharma Ltd | 2.10m | -5.59m | 93.62m | -- | -- | 2.96 | -- | 44.50 | -0.0333 | -0.0333 | 0.0126 | 0.1741 | 0.1183 | -- | 8.22 | -- | -31.44 | -- | -32.47 | -- | -- | -- | -265.90 | -- | 45.76 | -62.54 | 0.00 | -- | 4,164.38 | -- | 19.57 | -- | -- | -- |
| Tetratherix Ltd | 1.14m | -9.43m | 100.55m | -- | -- | 6.83 | -- | 88.00 | -0.1873 | -0.1873 | 0.0227 | 0.5414 | 0.0688 | -- | 2.22 | -- | -56.71 | -- | -76.72 | -- | -172.06 | -- | -824.89 | -- | -- | -98.75 | 0.0697 | -- | 32.30 | -- | -269.05 | -- | -- | -- |
| Island Pharmaceuticals Ltd | 58.80k | -3.92m | 103.59m | -- | -- | 12.70 | -- | 1,761.65 | -0.0224 | -0.0224 | 0.0003 | 0.0303 | 0.0117 | -- | 0.1099 | -- | -77.95 | -72.12 | -90.37 | -81.53 | -- | -- | -6,666.91 | -19,239.15 | -- | -162.89 | 0.00 | -- | 1,148.41 | -- | -36.86 | -- | -- | -- |
| Bioxyne Ltd | 28.43m | 4.90m | 107.52m | 16.00 | 20.69 | 8.37 | 18.90 | 3.78 | 0.0023 | 0.0023 | 0.0132 | 0.0057 | 2.16 | 6.30 | 17.06 | -- | 37.31 | -28.17 | 55.76 | -38.16 | 36.32 | 35.97 | 17.24 | -24.14 | 1.90 | -- | 0.1125 | -- | 204.87 | 65.94 | 138.29 | -- | 127.89 | -- |
| Arovella Therapeutics Ltd | 525.53k | -7.51m | 111.71m | 14.00 | -- | 5.51 | -- | 212.57 | -0.0067 | -0.0067 | 0.0005 | 0.0169 | 0.0301 | -- | -- | -- | -43.05 | -75.94 | -47.90 | -90.89 | -- | -- | -1,428.87 | -2,386.13 | -- | -- | 0.00 | -- | 237.44 | -1.82 | 14.14 | -- | 1.23 | -- |
| Paradigm Biopharmaceuticals Ltd | 7.11m | -18.77m | 130.10m | -- | -- | 5.51 | -- | 18.31 | -0.047 | -0.047 | 0.0183 | 0.0544 | 0.2684 | -- | 1.14 | -- | -70.91 | -67.55 | -80.99 | -75.98 | 99.71 | 99.24 | -264.18 | -527.01 | -- | -9,722.29 | 0.0003 | -- | 10.29 | 8.87 | 68.04 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Alterity Therapeutics Ltd's reporting currency: Australian Dollar AUD
4.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Pengana Capital Ltd.as of 31 Oct 2025 | 355.42m | 3.27% |
| Pictet Asset Management SAas of 30 Jun 2025 | 79.28m | 0.73% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 61.67m | 0.57% |
| Pictet Asset Management (Singapore) Pte Ltd.as of 30 Jun 2025 | 34.10m | 0.31% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
